Based on the provided SOAP note and test results, let's analyze the patient's condition:

### Subjective:

- **Chief Complaint (CC):** The patient reports chest pain and shortness of breath, which are concerning symptoms that could indicate a range of cardiovascular issues, including coronary artery disease (CAD), especially given the patient's risk factors.
- **History of Present Illness (HPI):** The characteristics of the chest pain and its association with physical activity suggest a cardiac origin, possibly ischemic in nature.
- **Review of Systems (ROS):** The occasional cough might not be directly related to the chief complaint but is worth noting.
- **Past Medical History (PMH):** Hypertension and Type 2 Diabetes Mellitus are significant risk factors for cardiovascular diseases, including CAD.
- **Family History (FH):** A family history of coronary artery disease further increases the patient's risk.
- **Social History (SH):** Smoking is a major risk factor for CAD. The patient's occupation as a construction worker implies potential for physical exertion, which might exacerbate symptoms.
- **Medications:** The patient is on Lisinopril for hypertension and Metformin for diabetes, both of which are appropriate but do not directly address the potential for CAD.
- **Allergies:** No known drug allergies.

### Objective:

- **Lab Results:** The CBC shows signs of microcytic hypochromic anemia, which could be related to chronic disease or nutritional deficiencies but is less likely to be directly related to the chief complaint. The elevated total bilirubin and indirect bilirubin suggest some degree of hemolysis or liver dysfunction, which could be a secondary finding or unrelated to the primary complaint. Liver enzymes are within normal limits, suggesting no acute liver injury.
- **Liver Panel:** The elevated bilirubin levels and the suggestion of possible NAFLD (Non-Alcoholic Fatty Liver Disease) are notable but not directly related to the chest pain and shortness of breath.

### Assessment:

1. **Primary Assessment:** The primary concern remains stable angina pectoris secondary to suspected coronary artery disease, given the patient's symptoms, risk factors, and family history.
2. **Secondary Assessments:**
   - Microcytic hypochromic anemia, possibly due to chronic disease or nutritional deficiency. Thalassemia minor is also a consideration given the recommendation for Hb HPLC.
   - Elevated bilirubin levels suggest some degree of hemolysis or liver dysfunction, which warrants further investigation but is not the immediate concern.

### Plan:

- **Immediate:** The plan to prescribe Nitroglycerin for chest pain and schedule a stress test and echocardiogram is appropriate for the assessment of CAD. Starting a statin is also prudent given the patient's risk profile.
- **Long-term:** Addressing the patient's anemia and elevated bilirubin levels will require further investigation. The recommendation for Hb HPLC to rule out Thalassemia Minor is appropriate. Additionally, evaluating the patient for NAFLD and potential causes of liver dysfunction is necessary, though this may be a secondary priority to the cardiovascular assessment.
- **Lifestyle:** The patient should be strongly encouraged to quit smoking, as this is a major modifiable risk factor for CAD. Dietary modifications and physical activity, as tolerated, should also be part of the long-term management plan.

### Follow-up:

- **Cardiology Referral:** Given the suspected CAD, referral to a cardiologist for further evaluation and management is appropriate.
- **Hematology Consultation:** Consideration for referral to a hematologist for evaluation of the anemia and elevated bilirubin, especially if Thalassemia Minor is confirmed or if other hematological conditions are suspected.
- **Gastroenterology Consultation:** If liver function tests worsen or if symptoms suggestive of liver disease develop, a consultation with a gastroenterologist may be warranted.

This comprehensive approach addresses the immediate concerns related to the patient's cardiovascular risk and symptoms, while also planning for the investigation and management of secondary findings that could impact the patient's overall health.